Episode 16: The future of medicine using microchips

Share:

Listens: 0

TalkingMed

Miscellaneous


This week we review 1) Psoriasis: Parisi R, Webb RT, Carr MJ, Moriarty KJ, Kleyn CE, Griffiths CEM, Ashcroft DM. Alcohol-Related Mortality in Patients With Psoriasis: A Population-Based Cohort Study. JAMA Dermatol. Published online September 15, 2017. doi:10.1001/jamadermatol.2017.3225 https://www.aad.org/public/diseases/scaly-skin/psoriasis#medication 2) Stroke Medications: Hong K, Kwon SU, Lee SH, Lee JS, Kim Y, Song T, Kim YD, Park M, Kim E, Cha J, Sung SM, Yoon B, Bang OY, Seo W, Hwang Y, Ahn SH, Kang D, Kang HG, Yu K, for the Phase 2 Exploratory Clinical Study to Assess the Effects of Xarelto (Rivaroxaban) Versus Warfarin on Ischemia, Bleeding, and Hospital Stay in Acute Cerebral Infarction Patients With Non-valvular Atrial Fibrillation (Triple AXEL) Study Group. Rivaroxaban vs Warfarin Sodium in the Ultra-Early Period After Atrial Fibrillation–Related Mild Ischemic StrokeA Randomized Clinical Trial. JAMA Neurol. Published online September 11, 2017. doi:10.1001/jamaneurol.2017.2161 3) Healthcare in Politics: Kurtzleben, Danielle. "Here's What's In Bernie Sanders' 'Medicare For All' Bill." NPR. NPR, 14 Sept. 2017. Web. 17 Sept. 2017. 4) ATOMS: Manuel Monge, Audrey Lee-Gosselin, Mikhail G. Shapiro, Azita Emami. Localization of microscale devices in vivo using addressable transmitters operated as magnetic spins. Nature Biomedical Engineering, 2017; 1 (9): 736 DOI: 10.1038/s41551-017-0129-2 http://www.caltech.edu/news/medicine-future-new-microchip-technology-could-be-used-track-smart-pills-79601 Welcome to TalkingMed, the podcast where we discuss current medical news. Contact: talkingmedpodcast@gmail.com Twitter: @TalkingMedPod Song credit: Night Owl by Broke For Free from the Free Music Archive, used under CCBY Attribution License, modified from the original. Disclaimer: The information presented on this podcast are our own personal views, opinions, and research on the subject matter and do not represent those of our institution or our department. Anything discussed on this podcast should not be considered medical advice. Please contact a professional if you have any medical concerns. All content found on TalkingMed, including text, images, audio, or other formats were created for informational purposes only. The content is not intended to be a substitute for professional medical advice, diagnosis, or treatment. Always seek the advice of your physician or another qualified health provider with any questions you may have regarding a medical condition. Never disregard professional medical advice or delay in seeking it because of something you have learned it from TalkingMed. Under no circumstances shall Vivek, Stephen, TalkingMed, any guests or contributors to the podcast or blog, or any employees, associates, or affiliates of TalkingMed be responsible for damages arising from use of the podcast or blog. This podcast or blog should not be used in any legal capacity whatsoever, including but not limited to establishing “standard of care” in a legal sense or as a basis for expert witness testimony. No guarantee is given regarding the accuracy of any statements or opinions made on the podcast or blog. You hereby acknowledge that nothing contained on TalkingMed shall constitute financial, investment, legal and/or other professional advice and that no professional relationship of any kind is created between you and the TalkingMed. You hereby agree that you shall not make any financial, investment, legal and/or other decision based in whole or in part on anything contained on TalkingMed. Nothing on TalkingMed or included as a part of TalkingMed should be construed as an attempt to offer or render a medical opinion or otherwise engage in the practice of medicine. If you think you may have a medical emergency, call your doctor, go to the emergency department, or call 911 immediately.  The content may contain health- or medical-related materials or discussions regarding sexually explicit disease states. If you find these materials offensive, you may not want to use this content.